Wuxia Quan

Wuxia Quan

Auto-generated profile, based on publicly available information

Wuxia Quan

Qingyang People's Hospital, Qingyang City, Gansu Province, P.R. China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2022 in IET Systems Biology
Verified
Journal Article
Open access
PDF file
YMYandong Miao
Yandong Miao
BSBin Su
Bin Su
XTXiaolong Tang
Xiaolong Tang
JWJiangtao Wang
Jiangtao Wang
WQWuxia Quan
Wuxia Quan
DMDenghai Mi
Denghai Mi
N6‐methyladenosine (m 6 A) RNA methylation is correlated with carcinogenesis and dynamically possessed through the m 6 A RNA methylation regulators. This paper aimed to explore 13 m 6 A RNA methylation regulators' role in gastrointestinal cancer (GIC) and determine the risk model and prognosis value of m 6 A RNA methylation regulators in GIC. We used several bioinformatics methods to identify the differential expression of m 6 A RNA methylation regulators in GIC, constructed a prognostic model, and carried out functional enrichment analysis. Eleven of 13 m 6 A RNA methylation regulators were differentially expressed in different clinicopathological characteristics of GIC, and m 6 A RNA methylation regulators were nearly associated with GIC. We constructed a risk model based on five m 6 A RNA methylation regulators (METTL3, FTO, YTHDF1, ZC3H13, and WTAP); the risk score is an independent prognosis biomarker. Moreover, the five m 6 A RNA methylation regulators can also forecast the 1‐, 3‐ and 5‐year overall survival through a nomogram. Furthermore, four hallmarks of oxidative phosphorylation, glycolysis, fatty acid metabolism, and cholesterol homoeostasis gene sets were significantly enriched in GIC. m 6 A RNA methylation regulators were related to the malignant clinicopathological characteristics of GIC and may be used for prognostic stratification and development of therapeutic strategies.

1 January 2023 in Combinatorial Chemistry & High Throughput Screening
Verified
Journal Article
Closed access
PDF file
YMYandong Miao
Yandong Miao
DMDenghai Mi
Denghai Mi
LMLinjie Mu
Linjie Mu
YCYong-Gang Chen
Yong-Gang Chen
XTXiaolong Tang
Xiaolong Tang
WQWuxia Quan
Wuxia Quan
Background Gastrointestinal cancer (GIC) is a prevalent and lethal malignant tumor. It is obligatory to investigate innovative biomarkers for the diagnosis and prognosis. Proteins play a crucial role in regulating the occurrence and progression of GIC. However, the prognostic value of proteins is unclear in GIC. Objective: This paper aims to identify the hub prognosis-related proteins (PAPs) and construct a prognosis model to GIC patients for clinical application. Methods: Protein expression data of GIC were obtained from The Cancer Proteome Atlas (TCPA) and downloaded the clinicopathological data from The Cancer Genome Atlas database (TCGA). Besides, hub proteins were filtrated out via univariate and multivariate Cox regression analysis. Moreover, survival analysis and nomogram were used to predict overall survival (OS). We used the calibration curves to assess the predictive and actual survival rate consistency. The consistency index (C-index) was used to evaluate the prognostic ability of the predictive model. Furthermore, functional enrichment analysis and protein co-expression of PAPs were used to explore their roles in GIC. Results: Finally, a prognosis model was conducted based on ten PAPs (CYCLIND1, DVL3, NCADHERIN, SYK, ANNEXIN VII, CD20, CMET, RB, TFRC, and PREX1). The risk score calculated by the model was an independent prognostic predictor. Compared with the high-risk subgroup, the low-risk subgroup had better OS. In the TCGA cohort, the area under the curve value of the receiver operating characteristic curve of the prognostic model was 0.692. The expression of proteins and risk score had a significant association with the clinicopathological characteristics of GIC. Besides, nomogram based on GIC clinicopathological feature and risk score could properly predict the OS of individual GIC patients. The C-index is 0.71 in the TCGA cohort and 0.73 in the GEO cohort, respectively. Conclusion: The results indicate that the risk score is an independent prognostic biomarker and is related to the malignant clinical features of GIC patients. Besides, several PAPs, associated with the survival and clinicopathological characteristics of GIC might be potential biomarkers for GIC diagnosis and treatment.